The US FDA authorizes the Novavax COVID vaccine for adults
July 13 (Reuters) – The U.S. Food and Drug Administration on Wednesday authorized the use of Novavax Inc.’s COVID-19 vaccine (NVAX.O), paving the way for a more traditional vaccine technology. which has aroused hope for wider acceptance among vaccine skeptics. Shares of Novavax rose 1.3% to $ 70.89 after its two-dose vaccine became the fourth …
The US FDA authorizes the Novavax COVID vaccine for adults Read More »